A robust host-response-based signature distinguishes bacterial and viral infections across diverse global populations

Cell Rep Med. 2022 Dec 20;3(12):100842. doi: 10.1016/j.xcrm.2022.100842.

Abstract

Limited sensitivity and specificity of current diagnostics lead to the erroneous prescription of antibiotics. Host-response-based diagnostics could address these challenges. However, using 4,200 samples across 69 blood transcriptome datasets from 20 countries from patients with bacterial or viral infections representing a broad spectrum of biological, clinical, and technical heterogeneity, we show current host-response-based gene signatures have lower accuracy to distinguish intracellular bacterial infections from viral infections than extracellular bacterial infections. Using these 69 datasets, we identify an 8-gene signature to distinguish intracellular or extracellular bacterial infections from viral infections with an area under the receiver operating characteristic curve (AUROC) > 0.91 (85.9% specificity and 90.2% sensitivity). In prospective cohorts from Nepal and Laos, the 8-gene classifier distinguished bacterial infections from viral infections with an AUROC of 0.94 (87.9% specificity and 91% sensitivity). The 8-gene signature meets the target product profile proposed by the World Health Organization and others for distinguishing bacterial and viral infections.

Keywords: antimicrobial resistance; bacterial vs. viral diagnosis; gene expression; global health; host response; infectious disease diagnosis; point-of-care diagnostics; public health.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Bacterial Infections* / diagnosis
  • Humans
  • Prospective Studies
  • Sensitivity and Specificity
  • Transcriptome
  • Virus Diseases* / diagnosis